Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
about
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779Sirolimus: continuing the evolution of transplant immunosuppression.Sirolimus enhances cyclosporine a-induced cytotoxicity in human renal glomerular mesangial cells
P2860
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@en
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@nl
type
label
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@en
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@nl
prefLabel
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@en
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@nl
P1476
Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients.
@en
P2093
P304
P356
10.1016/S0041-1345(98)00585-5
P407
P577
1998-08-01T00:00:00Z